Augmented Reality Aided Remote Access and Technical Support for Complex Ablation Procedures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Luebeck

About this trial

Prospective, randomized, controlled, single-center pilot study evaluating the feasibility and safety of augmented reality-based remote technical support using the Microsoft HoloLens and EnSite™ Connected Care compared with conventional on-site support during 3D electroanatomical mapping-guided electrophysiological procedures. The study also assesses the feasibility of an AI-based algorithm integrated into the Medinbox Link system for automated procedural report generation and detection of protocol deviations from standard clinical practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients age ≥ 18 years

Indication for 3D electroanatomical mapping-based catheter ablation for the treatment of AF

Signed written informed consent

Disqualifiers

Patient is unable or unwilling to provide informed consent

Patient is included in another randomised clinical trial

Inability to comply with the study procedures

Trial design

Design model

Parallel

Treatments tested in this trial

  • HoloLens supported catheter ablation

    Procedure/Surgery

    Patients undergoing 3D electroanatomical mapping-based AF ablation procedures using the EnSite™ X EP System operated remotely by means of the EnSite™ Connected Care solution (EnSite™ Connect Remote Support, Abbott and Medinbox system, Medinbox) and the Microsoft HoloLens (Microsoft). The HoloLens headset will be implemented to facilitate the communication between the principal operator and the FTE (working in Home Office). The FTE will not be present on site.

  • On-site supported catheter ablation

    Procedure/Surgery

    Patients undergoing 3D electroanatomical mapping-based AF ablation procedures using the EnSite™ X EP System operated by the FTE on site, in the Minimal Invasive Centre (MIC) of the hospital. The HoloLens headset and the EnSite™ Connected Care solution will not be used. The communication between the operator (in the operating room) and the FTE (in the control room) will be established by means of radio-based headphones.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: HoloLens GroupExperimental treatment 1 intervention
Group B: On-site GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility: Number of participants in whom remotely supported 3D electroanatomical mapping-based atrial fibrillation ablation is successfully completed

Feasibility will be assessed as the number and percentage of participants in whom the planned 3D electroanatomical mapping-guided atrial fibrillation ablation procedure is successfully completed using remote technical support provided through an augmented reality system (Microsoft HoloLens headset) in conjunction with the EnSite™ Connected Care solution (EnSite™ Connect Remote Support, Abbott) and the Medinbox system. Successful completion is defined as completion of the planned mapping and ablation procedure without conversion to on-site technical support because of technical failure of the remote support system.

Time frame
At the end of the catheter ablation procedure.

Secondary outcomes

1

Number of participants with periprocedural adverse events

Periprocedural adverse events occurring during the catheter ablation procedure and throughout the index hospitalization will be recorded.

Time frame
Periprocedural (from initiation of the catheter ablation procedure until hospital discharge)
2

Procedural time

Procedural time

Time frame
At the end of catheter ablation procedure
3

Fluoroscopy time

Total fluoroscopy time (minutes) recorded during the catheter ablation procedure.

Time frame
End of the catheter ablation procedure
4

Number of participants with successful completion of the intended catheter ablation procedure (the minimum procedural endpoint is successful pulmonary vein isolation)

Procedural success will be assessed as successful completion of the intended catheter ablation procedure. A minimum procedural endpoint is successful pulmonary vein isolation (PVI), confirmed by entrance block in all pulmonary veins. Additional ablations may be performed at the operator's discretion based on the patient's clinical characteristics and the planned treatment strategy. When additional ablations are planned or performed, procedural success also requires successful completion of these additional lesion sets according to the predefined procedural objectives.

Time frame
End of the catheter ablation procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: